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WEST NILE VIRUS: AN OLD TALE, NEW MYSTERY
Seetha Venkateswaran MD & Patricia Gilford MD
Orange Park Medical Center, Orange Park, FL

CASE
•
•
•
•
•
•
•

Figure 2: T2 weighted MRI image will indicate
High Signal Intensity and Swelling in the
Thalamus in patients with West Nile Virus
Encephalitis. Hemorrhage may also be noted
in this area on occasion.

Elderly male with a past medical history of prostate cancer status-post radiation, myocardial
infarction with stents and hypertension presented with a one week history of generalized
weakness, decreased appetite and non-productive cough. Vitals signs were: Temp 102.5 F,
pulse 77, RR 19, BP 125/65, O2 saturation 96% room air.
Patient was alert and oriented x3, diminished airflow bi-basilar in nature and diminished lower
extremity reflexes. Labs were significant only for serum sodium of 130.
Over 24 hours, patient had worsening weakness, prominent in the lower extremities with
persistent diminished reflexes and non-sustained ventricular tachycardia.
Progressively unstable vital signs and encephalopathy led to the patient being transferred to
ICU and subsequently intubated.

Classic MRI findings include:
1. Hyperintensity in the Basal Ganglia and
Thalamus.

CT head/chest and thoracic/lumbar MRI were unrevealing for overt pathology. Urinalysis,
blood and stool cultures were negative.
Lumbar puncture (LP) was contraindicated at time of ICU admission secondary to Plavix use.
Patient was empirically treated with cefepime and doxycycline for recent travel to Lyme
disease endemic area of North Carolina/Tennessee and with IVIG for questionable Acute
Inflammatory Demyelinating Polyneuropathy (AIDP).

2.Restricted diffusion in the Basal Ganglia and
Thalamus

Eventual LP analysis was positive for CSF pleocytosis and West Nile anti-bodies (IgM/IgG).
Patient was unable to be weaned off ventilator and underwent tracheostomy/gastrostomy
tube placement and transferred to long-term acute care facility for further management.

FUTURE DIRECTION / CONCLUSION

BACKGROUND
•
•
•
•
•
•
•

West Nile Virus (WNV), belongs to the Flavivirus family, is considered an endemic disease in
many states including Florida.

•

In the last decade, the virus has been prominently reported in the Southern and Midwest
States.

•

The disease is most prevalent during the summer to fall month periods due to elevated
temperatures leading to enhanced vector transmission.

•

DISCUSSION

WNV is acquired via the bite of an infected mosquito particularly the Culex species, and is
considered as the vector for the disease.
Equines and humans are incidental hosts of WNV and disease transmission from these
sources are rare. There are various human risk factors that are associated with WNV.
Disease prevalence is reported to be equal among the sexes but peak incidence and
mortality rates are seen among those who are 50 years of age and older, with a reported
increase of encephalitis or meningitis variants of the disease.
Comorbidities such as diabetes, hypertension and other chronic illnesses have not been
linked to WNV prevalence and disease outcomes.

•
•
•
•

Figure 1

•
•
•

The case is unique in the rarity of disease presentation, as literature review indicates that <1% of
patients develop West Nile neuro-invasive disease (WNND), which includes (encephalitis and/or
myelitis), resulting in long-term neurological deficits.

Strategies can be adopted by family practice focused on improving patient learning on prevention
techniques such as using DEET containing repellents and outdoor protection with appropriate attire.
Education on symptom recognition is crucial with severe manifestations including convulsions,
weakness and paralysis or mild effects of nausea, vomiting and myalgia.
It is also important to note that a vast majority of patients may be asymptomatic in the initial stages
of infection, with no discernible diagnostic test to determine if a person may develop disease
manifestation.
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WNV is an important cause of viral encephalitis epidemic in the country and has been well
recognized as an established seasonal epidemic.
It is critical for Family Physicians across the nation, especially for those practicing in endemic
areas, to include WNV in the differential disease panel for patients in the primary care setting,
presenting with vague symptoms and undifferentiated/unexplained weakness and symptoms.
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